| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.672 | 34.000 | 34.245 | 39.397 | 43.012 | 51.371 | 56.575 | 65.114 | 77.391 | 88.309 |
| Total Income - EUR | 33.946 | 35.518 | 34.275 | 41.601 | 43.015 | 51.373 | 56.894 | 85.507 | 77.519 | 88.313 |
| Total Expenses - EUR | 22.988 | 29.731 | 14.279 | 26.968 | 26.770 | 38.902 | 34.901 | 55.490 | 36.966 | 51.568 |
| Gross Profit/Loss - EUR | 10.958 | 5.787 | 19.996 | 14.632 | 16.245 | 12.470 | 21.993 | 30.017 | 40.553 | 36.745 |
| Net Profit/Loss - EUR | 9.945 | 5.083 | 19.417 | 14.217 | 15.841 | 11.978 | 21.472 | 29.265 | 39.866 | 29.915 |
| Employees | 2 | 2 | 1 | 2 | 2 | 3 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Sano Simfamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.529 | 3.515 | 2.146 | 176 | 13.180 | 10.583 | 14.988 | 30.815 | 30.048 | 25.202 |
| Current Assets | 53.925 | 57.966 | 54.897 | 20.875 | 18.845 | 15.897 | 17.409 | 20.407 | 28.354 | 43.279 |
| Inventories | 51 | 357 | 351 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.005 | 4.293 | 9.907 | 2.247 | 4.637 | 4.236 | 5.161 | 5.290 | 11.725 | 22.416 |
| Cash | 49.869 | 53.316 | 44.639 | 18.627 | 14.209 | 11.661 | 12.248 | 15.118 | 16.629 | 20.863 |
| Shareholders Funds | 39.799 | 44.476 | 41.007 | 14.311 | 15.934 | 12.077 | 21.569 | 29.362 | 39.963 | 30.012 |
| Social Capital | 45 | 45 | 44 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 18.655 | 17.006 | 16.037 | 6.740 | 16.113 | 14.403 | 10.828 | 21.860 | 18.438 | 38.470 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Sano Simfamed S.r.l.